Chemed Corporation (NYSE:CHE) Given Average Rating of “Hold” by Analysts

Shares of Chemed Corporation (NYSE:CHE) have been assigned an average rating of “Hold” from the six brokerages that are currently covering the stock, MarketBeat reports. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $501.50.

Several brokerages recently weighed in on CHE. Royal Bank Of Canada raised their price target on shares of Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research report on Monday, April 27th. Weiss Ratings raised Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Finally, Wall Street Zen lowered Chemed from a “buy” rating to a “hold” rating in a report on Monday, June 8th.

Chemed Stock Performance

CHE opened at $489.54 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.83 and a debt-to-equity ratio of 0.11. The company’s fifty day moving average price is $436.14 and its two-hundred day moving average price is $426.84. Chemed has a 1-year low of $365.20 and a 1-year high of $492.30. The company has a market cap of $6.50 billion, a price-to-earnings ratio of 26.68, a PEG ratio of 1.81 and a beta of 0.52.

Chemed (NYSE:CHE) last released its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, beating analysts’ consensus estimates of $5.30 by $0.35. The firm had revenue of $657.51 million for the quarter, compared to analyst estimates of $659.22 million. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The business’s quarterly revenue was up 1.6% compared to the same quarter last year. During the same period last year, the firm earned $5.63 earnings per share. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, analysts expect that Chemed will post 22.67 EPS for the current fiscal year.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Investors of record on Thursday, May 28th were given a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend was Thursday, May 28th. Chemed’s dividend payout ratio is presently 13.08%.

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Friday, May 1st. The shares were sold at an average price of $421.13, for a total transaction of $842,260.00. Following the transaction, the chief executive officer directly owned 90,219 shares of the company’s stock, valued at $37,993,927.47. The trade was a 2.17% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Andrea R. Lindell sold 1,347 shares of the company’s stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the sale, the director owned 4,578 shares of the company’s stock, valued at approximately $2,047,876.74. The trade was a 22.73% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 3.33% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB increased its stake in Chemed by 65.3% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 81 shares of the company’s stock valued at $38,000 after buying an additional 32 shares during the last quarter. Versant Capital Management Inc grew its holdings in shares of Chemed by 7,500.0% in the second quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock valued at $35,000 after acquiring an additional 75 shares in the last quarter. Maripau Wealth Management LLC grew its holdings in shares of Chemed by 5.4% in the first quarter. Maripau Wealth Management LLC now owns 970 shares of the company’s stock valued at $366,000 after acquiring an additional 50 shares in the last quarter. Segall Bryant & Hamill LLC purchased a new stake in shares of Chemed during the first quarter valued at approximately $2,293,000. Finally, Cim LLC increased its position in shares of Chemed by 1.6% during the first quarter. Cim LLC now owns 2,325 shares of the company’s stock valued at $878,000 after acquiring an additional 37 shares during the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.